Taro Pharmaceutical Industries Ltd
Taro Pharmaceutical Industries Lt.../ IL0010827181 /
TARO
|
2024-04-26 10:10:00 PM
|
Chg.
-0.08
|
Volume |
Bid2:00:00 AM |
Ask2:00:00 AM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
42.40USD
|
-0.19%
|
27,112
Turnover: 856,070.76 |
41.51Bid Size: 100 |
43.33Ask Size: 100 |
1.59 bill.USD |
- |
58.12 |
Business description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products.
Management board & Supervisory board
| CEO |
| Uday Baldota |
| Management board |
| William J. Coote, Vikash Agarwal, Avi Avramoff, Victoria Chester, Anthony Dolan, Moshe Gavrilov, Nivaran Kapur, David Kinzelberg, Karen Lowney, Barb Pimentel, Hagai Reingold, Michele Visosky, Erik Zwicker |
| Supervisory board |
| Dilip Shanghvi, Abhay Gandhi, Uday Baldota, Linda Benshoshan, James Kedrowski, Dr. Robert Stein, Sudhir Valia |
Company data
| Name: |
Taro Pharmaceutical Industrie |
| Address: |
14 Hakitor Street, Haifa Bay,Haifa 2624761 |
| Phone: |
+972 4 847 5700 |
| Fax: |
- |
| E-mail: |
-
|
| Internet: |
https://www.taro.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
03-30 |
| Free Float: |
- |
| IPO date: |
1961-01-01 |
